Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Godefridus J. Peters; Elisa Giovannetti; Richard J. Honeywell; Joseph Ciccolini

doi:https://doi.org/10.1111/bcp.13921

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Godefridus J. Peters, Elisa Giovannetti, Richard J. Honeywell, Joseph Ciccolini

Research output: Contribution to journal › Comment/Letter to the editor › Academic

7 Citations (Scopus)

Original language	English
Pages (from-to)	1213-1214
Number of pages	2
Journal	British journal of clinical pharmacology
Volume	85
Issue number	6
DOIs	https://doi.org/10.1111/bcp.13921
Publication status	Published - 1 Jun 2019

Keywords

cytidine deaminase
gemcitabine
therapeutic drug monitoring

Access to Document

https://doi.org/10.1111/bcp.13921

Cite this

@article{c5a7b603f28c47cc996ebce25dfc5df3,

title = "Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?",

keywords = "cytidine deaminase, gemcitabine, therapeutic drug monitoring",

author = "Peters, {Godefridus J.} and Elisa Giovannetti and Honeywell, {Richard J.} and Joseph Ciccolini",

year = "2019",

month = jun,

day = "1",

doi = "https://doi.org/10.1111/bcp.13921",

language = "English",

volume = "85",

pages = "1213--1214",

journal = "British journal of clinical pharmacology",

issn = "0306-5251",